Immuno-protective impact and clinical translation of radioprotective agents in cancer radiotherapy
Radiotherapy, as a key component of the comprehensive treatment system for malignant tumors, not only facilitates precise tumor destruction but also necessitates the strategic use of radioprotective agents to regulate immune responses and mitigate toxicity in normal tissues. Revealing the molecular...
Saved in:
| Main Authors: | Yiyong Huang, Xiaolan Lv, Tao Si, Xia Meng, Xiaolin Liao, Pengfei Zhang, Zheng Peng, Zheyi Zhou, Ping Yi, Shigao Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1610296/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of the radioprotective properties of 3-hydroxypyridine fumarate on an invertebrate animal model after proton irradiation <i>in vivo</i>
by: O. V. Kuzmicheva, et al.
Published: (2025-04-01) -
RADIATION ACCIDENTS: EXPERIENCE OF MEDICAL PROTECTION AND MODERN STRATEGY OF PHARMACOLOGICAL MAINTENANCE
by: A. N. Grebenyuk, et al.
Published: (2015-09-01) -
Oncobiomics: Leveraging Microbiome Translational Research in Immuno-Oncology for Clinical-Practice Changes
by: Carolina Alves Costa Silva, et al.
Published: (2025-03-01) -
New approach to evaluate the exit dose quality for high radioprotection and radiotherapy efficiency
by: Mohamed Bencheikh, et al.
Published: (2018-12-01) -
Multifunctional Biomimetic Nanocarriers for Dual‐Targeted Immuno‐Gene Therapy Against Hepatocellular Carcinoma
by: Yupeng Sun, et al.
Published: (2024-09-01)